Most stem cell clinics today offer mesenchymal stem cells (MSCs), which function primarily as medicinal signaling cells. They reduce inflammation but don’t actually regenerate new tissue. While helpful for temporary relief, this often leads to a misunderstanding many patients believe they’re receiving regenerative treatments when they’re really getting anti-inflammatory therapy. On the other hand, clinics offering embryonic or fetal stem cells (or even induced pluripotent stem cells, iPSCs) aim

Groundbreaking Stem Cell Trial Offers Hope for Spinal Cord Injury Patients In a pioneering clinical study led by Professor Hideyuki Okano at Keio University, Tokyo, scientists have taken a major step toward restoring mobility after spinal cord injury. Four adult men who had suffered complete paralysis (AIS A) received injections of about two million neural precursor cells, derived from donor induced pluripotent stem (iPS) cells, directly into the injured area of the spinal cord. The treatment wa